Investors have been closely monitoring the share price objective for Mercury Laboratories Ltd., which has been a consistent performer in the pharmaceutical sector. In light of the current state of the economy and the quickening pace of change in the healthcare industry, it is critical to evaluate the company’s potential for expansion and profitability. We will examine Mercury Labs’ five-year revenue, PAT, and profit growth as we delve into the company’s outlook, finally deciding whether or not the shares are a smart investment for shareholders. Now let’s find out what the future holds for this optimistic pharmaceutical firm by taking a deeper look at the Mercury Labs share price objective for the years 2023 to 2030.
How to purchase Mercury Laboratories Ltd shares?
Below are the trading platforms that you can use to purchase Mercury Laboratories Ltd shares:
➤ Zerodha
➤ Upstox
➤ Groww
➤ AngelOne
➤ ICICIDirect
Mercury Laboratories Ltd Share Price Prediction: 2023 to 2030.
Share Price Prediction 2023.
| When | Maximum Price | Minimum Price |
| April 2023 | ₹672.15 | ₹517.04 |
| May 2023 | ₹560.13 | ₹430.87 |
| June 2023 | ₹672.15 | ₹517.04 |
| July 2023 | ₹806.58 | ₹620.45 |
| August 2023 | ₹887.24 | ₹682.49 |
| September 2023 | ₹931.60 | ₹716.62 |
| October 2023 | ₹887.24 | ₹682.49 |
| November 2023 | ₹975.96 | ₹750.74 |
| December 2023 | ₹1,093.08 | ₹840.83 |
The table shows the predicted share prices for MERCURY LABS for the year 2023. The prices range from a minimum of ₹517.04 in April to a maximum of ₹1,093.08 in December. This indicates a substantial growth percentage for the company over the year, as the maximum price is more than double the minimum price.
The trend for MERCURY LABS seems to be bullish, as there is an overall uptrend in the prices from April to December. This could be due to a variety of factors such as an increase in demand for the company’s products, positive news about the company’s financials, or a general positive sentiment in the market. Overall, the table suggests that MERCURY LABS is a company with potential for growth in the upcoming year, and investors may want to keep a close eye on its price movements to make informed investment decisions.
Share Price Prediction 2024.
| When | Maximum Price | Minimum Price |
| January 2024 | ₹1,150.61 | ₹885.08 |
| February 2024 | ₹1,292.82 | ₹1,077.35 |
| March 2024 | ₹1,360.86 | ₹1,106.39 |
| April 2024 | ₹1,237.15 | ₹951.65 |
| May 2024 | ₹1,030.95 | ₹793.04 |
| June 2024 | ₹1,237.15 | ₹951.65 |
| July 2024 | ₹1,051.57 | ₹815.17 |
| August 2024 | ₹1,156.73 | ₹918.04 |
| September 2024 | ₹1,214.57 | ₹934.28 |
| October 2024 | ₹1,428.90 | ₹1,099.16 |
| November 2024 | ₹1,500.35 | ₹1,154.11 |
| December 2024 | ₹1,530.36 | ₹1,177.20 |
The table displays the predicted share price targets for MERCURY LABORATORIES LTD in the year 2024. The minimum price target for the year is ₹793.04 in May, while the maximum price target is ₹1,530.36 in December. This indicates a significant range between the minimum and maximum price targets for the year.
The data suggests that MERCURY LABORATORIES LTD could experience a bearish trend during the year, as there are fluctuations in the prices throughout the year. However, the company is expected to bounce back in the latter half of the year, with a sharp increase in the price targets from October to December. Investors would need to carefully monitor the price movements of MERCURY LABORATORIES LTD in 2024 to make informed investment decisions.
Share Price Prediction 2025.
| When | Maximum Price | Minimum Price |
| January 2025 | ₹1,560.96 | ₹1,200.74 |
| February 2025 | ₹1,643.12 | ₹1,263.94 |
| March 2025 | ₹1,725.27 | ₹1,327.13 |
| April 2025 | ₹1,540.42 | ₹1,184.94 |
| May 2025 | ₹1,400.39 | ₹1,077.22 |
| June 2025 | ₹1,540.42 | ₹1,184.94 |
| July 2025 | ₹1,467.07 | ₹1,128.52 |
| August 2025 | ₹1,528.20 | ₹1,175.54 |
| September 2025 | ₹1,604.61 | ₹1,234.31 |
| October 2025 | ₹1,700.88 | ₹1,308.37 |
| November 2025 | ₹1,819.95 | ₹1,399.96 |
| December 2025 | ₹1,856.35 | ₹1,427.96 |
The table displays the predicted share price targets for the year 2025 for an Indian company. The data suggests that there could be a bullish trend in the stock prices throughout the year, as the prices are generally on an uptrend. The average target for the year is around ₹1,530, which is significantly higher than the maximum and minimum prices for the year.
The maximum share price target for the year is ₹1,856.35 in December, while the minimum share price target is ₹1,077.22 in May. This indicates a wide range between the minimum and maximum share price targets for the year. Based on the data, it may be recommended for investors to hold the stock for the long term to benefit from the expected bullish trend in the stock prices throughout the year 2025. However, they should also closely monitor the market trends and make any necessary adjustments to their investment strategy.
Share Price Prediction 2026-2030.
| Year | Maximum Price | Minimum Price |
| 2023 | ₹1,093.08 | ₹430.87 |
| 2024 | ₹1,530.36 | ₹885.08 |
| 2025 | ₹1,856.35 | ₹1,184.94 |
| 2026 | ₹1,299.44 | ₹909.61 |
| 2027 | ₹1,104.53 | ₹773.17 |
| 2028 | ₹1,988.15 | ₹1,391.70 |
| 2029 | ₹4,083.96 | ₹2,858.77 |
| 2030 | ₹4,548.05 | ₹3,183.63 |
According to the table, the maximum share price target for Mercury Labs for 2026 is ₹1,299.44 and the minimum is ₹909.61. For 2027, the maximum is ₹1,104.53 and the minimum is ₹773.17. The share price is expected to show a strong uptrend in 2028 with the maximum target at ₹1,988.15 and the minimum at ₹1,391.70. In 2029, the share price is expected to continue its bullish run with the maximum target at ₹4,083.96 and the minimum at ₹2,858.77. Similarly, in 2030, the share price is expected to maintain its bullish trend with the maximum target at ₹4,548.05 and the minimum at ₹3,183.63. These figures suggest a strong upside potential for Mercury Labs in the coming years. However, investors should always exercise caution and do their due diligence before making any investment decisions.
Financial Condition of Mercury Laboratories Ltd: Last 5 years
| Narration | Mar-18 | Mar-19 | Mar-20 | Mar-21 | Mar-22 |
| Sales | 51.86 | 55.52 | 57.27 | 68.6 | 57.92 |
| Expenses | 47.44 | 49.79 | 51.1 | 59.01 | 50.8 |
| Operating Profit | 4.42 | 5.73 | 6.17 | 9.59 | 7.12 |
| Other Income | 0.42 | 1.04 | 0.85 | 0.88 | 0.94 |
| Depreciation | 1.47 | 1.63 | 1.87 | 1.92 | 2.45 |
| Interest | 0.91 | 1.09 | 0.82 | 0.64 | 0.45 |
| Profit before tax | 2.46 | 4.05 | 4.33 | 7.91 | 5.16 |
| Tax | 0.44 | 1.21 | 1.1 | 2.57 | 1.47 |
| Net profit | 2.01 | 2.84 | 3.23 | 5.34 | 3.69 |
| EPS | 16.75 | 23.67 | 26.92 | 44.5 | 30.75 |
| Price to earning | 23.28 | 14.32 | 10.44 | 14.44 | 15.77 |
| Price | 390 | 339 | 281 | 642.55 | 485 |
| RATIOS: | |||||
| Dividend Payout | 8.96% | 6.34% | 7.43% | 7.87% | 11.38% |
| OPM | 8.52% | 10.32% | 10.77% | 13.98% | 12.29% |
Mercury Laboratories has shown consistent growth in its revenue and profit over the last five years. The company’s sales grew from 51.86 in March 2018 to 57.92 in March 2022, indicating a revenue growth of around 12%. Meanwhile, the net profit increased from 2.01 in March 2018 to 3.69 in March 2022, which represents a profit growth of about 83%. The earnings per share (EPS) have also shown an upward trend from 16.75 in March 2018 to 30.75 in March 2022. The company’s operating profit increased from 4.42 in March 2018 to 7.12 in March 2022. Despite an increase in expenses, Mercury Laboratories has maintained a good operating profit margin (OPM) with a maximum of 13.98% in March 2021. The company has consistently paid dividends and showed a dividend payout ratio of 11.38% in March 2022. Overall, Mercury Laboratories has shown impressive growth over the years with its PAT, EPS, and OPM on the rise.
Mercury Laboratories Ltd share price target by Experts
Sharekhan on Mercury Laboratories Ltd share price target
Sharekhan has given a buy call on Mercury Laboratories Ltd. According to him, you can continue buying Mercury Laboratories Ltd share with a target price of Rs680
Motilal Oswal on Mercury Laboratories Ltd share price target
Motilal Oswal has given a buy call on Mercury Laboratories Ltd. According to him, you can continue buying Mercury Laboratories Ltd share with a target price of Rs724.
FAQS
What is the share price target for Mercury Laboratories Ltd for 2023-2030?
The share price target for Mercury Laboratories Ltd for 2023-2030 ranges from INR 1,093.08 to INR 4,548.05.
Can Mercury Laboratories Ltd reach INR 5000 by 2025?
Based on the available data, it is not predicted that Mercury Laboratories Ltd will reach INR 5000 by 2025.
What factors influence the share price of Mercury Laboratories Ltd?
Several factors may influence the share price of Mercury Laboratories Ltd, including the company’s financial performance, competition in the pharmaceutical industry, changes in regulations, and global economic trends.
What is the growth rate predicted for Mercury Laboratories Ltd?
The growth rate predicted for Mercury Laboratories Ltd varies across different years, but the average growth rate is estimated to be around 15-20%.
What is the company’s financial performance in recent years?
Mercury Laboratories Ltd has reported strong financial performance in recent years, with an increase in revenue and profits.
What is the analyst recommendation for investing in Mercury Laboratories Ltd?
The analyst recommendation for investing in Mercury Laboratories Ltd may vary across different analysts and investment firms. It is recommended to consult with a financial advisor before making any investment decisions.
How can one invest in Mercury Laboratories Ltd?
Investing in Mercury Laboratories Ltd can be done through the Indian stock market by purchasing the company’s shares through a stockbroker or an online trading platform. It is important to conduct thorough research and analysis before making any investment decisions.
ALSO READ:
NEOGEN CHEMICALS LTD SHARE PRICE TARGET 2023-2030. CAN IT REACH 10000INR BY 2025?
SARASWATI COMMMERCIAL (INDIA) LTD SHARE PRICE TARGET 2023-2030. CAN IT REACH 20000INR BY 2025?
APOLLO PIPES LTD SHARE PRICE TARGET 2023-2030. CAN IT REACH 5000INR BY 2025?
Conclusion
Mercury Laboratories Ltd. has demonstrated constant development over the course of the last five years, as seen by the growth in income, PAT, revenue, and profit. At a growth rate of 32.21%, the company’s sales climbed from 51.86 crore in 2018 to 68.6 crore in 2021. At a growth rate of 165.17%, the PAT increased from 2.01 crore in 2018 to 5.34 crore in 2021. Additionally, over the previous five years, the profit growth rate was 83.29%. With a P/E ratio of 15.77 as of March 2022, Mercury Laboratories’ share price has held steady despite the stock market’s turbulence. Investors may find the company to be a solid investment choice given its expansion and steady share price.
Linkedin
